BARCELONA — A new three-pronged approach to hepatitis C virus effectively treated prior non-responders...
Read More
BARCELONA — In this video perspective from the International Liver Congress, Fred Poordad, MD,...
– 95 percent of patients achieved SVR12 with 12 weeks of ABT-493 and ABT-530...
AbbVie (NYSE: ABBV) announced that 91 percent (n=20/22) of genotype 1 (GT1) chronic hepatitis...
http://medpagetoday.s3.amazonaws.com/media/sponsors/hothcv/Pipeline2.mp4 MedPage Today invited specialists from leading medical institutions to weigh in on the...
The U.S. Food and Drug Administration has granted amended Breakthrough Therapy Designation for an...
MedPage Today invited specialists from leading medical institutions to weigh in on the latest...
At the time, the medication Joey was taking kept the disease from progressing. But...
A medical breakthrough tested in San Antonio is opening doors for patients diagnosed with...
Treatment-naive and experienced patients with chronic hepatitis C virus genotype 1 infection without cirrhosis...